Georgia Capital PLC GHG digital application winning Gold Award (5164D)

TIDMCGEO

RNS Number : 5164D

Georgia Capital PLC

29 June 2021

London, 29 June 2021

GHG digital healthcare application winning Gold Award at EBRD Sustainability Awards 2021

Georgia Capital PLC announces that its 100% subsidiary, Georgia Healthcare Group ("GHG"), has today won the Gold Award in the Environmental & Social Innovation category at European Bank for Reconstruction and Development ("EBRD") Sustainability Awards 2021, for its new digital application - EKIMO.

EKIMO is an innovative, independent and fully integrated digital healthcare platform, that combines all components of primary healthcare: doctors, clinics, laboratories, radiology units, retail pharmacies and medical insurance. The application was launched in March 2020 and is open to any healthcare service provider or health product seller in the country. EKIMO is completely free for all users and provides quick and easy access to the entire healthcare ecosystem, such as: booking doctor appointments, online payments, online consultations, and pharmacy delivery.

Since its launch, EKIMO's network has expanded to 1,050 doctors from 60 different clinics, half of which are independent, third-party clinics. As of today, EKIMO is the largest digital healthcare platform in the country, from which more than 133,600 users are already benefiting.

Name of authorised official of issuer responsible for making notification: Giorgi Alpaidze, Chief Financial Officer

About Georgia Capital PLC

Georgia Capital is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 0.5 billion equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a healthcare services business; (ii) a water utility business; (iii) a retail (pharmacy) business, (iv) an insurance business (P&C and medical insurance); (v) a renewable energy business (hydro and wind assets) and (vi) an education business; Georgia Capital also holds other small private businesses across different industries in Georgia and a 19.9% equity stake in LSE premium-listed Bank of Georgia Group PLC ("Bank of Georgia"), a leading universal bank in Georgia.

 
 JSC Georgia Capital has, as of 
  the date hereof, the following 
  credit ratings: 
 S&P Global      'B'/FC & 'B'/LC 
 Moody's         B2/CFR & B2/PDR 
 

About Georgia Healthcare Group

Georgia Healthcare Group is the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 17 hospitals and 34 clinics. GHG is the single largest market participant, accounting for 20% of the total hospital bed capacity in the country, as of 31 March 2021. GHG is also the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 32% market share by revenue and the largest provider of medical insurance in Georgia with a 25% market share based on net insurance premiums earned and approximately c.172,000 insurance customers. GHG employed a total of c.15,200 people as at 31 March 2021, including c.3,500 physicians and 2,900 pharmacists.

For further information, please visit www.georgiacapital.ge or contact:

 
 Irakli Gilauri        Giorgi Alpaidze           Michael Oliver 
 Chairman and Chief    Chief Financial Officer   Adviser to the Chairman 
  Executive                                       & CEO 
 [e-mail]            [phone]          [phone] 
                       [e-mail]                [e-mail] 
 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUKAURAKUNUAR

(END) Dow Jones Newswires

June 29, 2021 08:30 ET (12:30 GMT)